Experimental Research about Preventing Posterior Capsular Opacification by Interleukin-1 Beta Antisense Oligodeoxynucleotide Liposomes

KE Zhisheng,CAI Xiaojun,DENG Xiaoyan
DOI: https://doi.org/10.3969/j.issn.1671-8852.2006.02.030
2006-01-01
Abstract:Objective: To investigate the effect of IL-1β antisense oligodeoxynucleotide(ASODN) liposomes in prevention of posterior capsular opacification. Methods: Extracapsular cataract extraction was performed on 30 rabbit eyes which were divided into three groups:control, liposome and ASODN group.The first control group were injected PBS in the operation, the liposome group were injected liposome, and the third were injected ASODN liposomes of IL-1β into the capsular bag during cataract extraction. The aqueous humors were drawn regularly and determined the concentration of IL-1β by enzyme-linked immunosorbent assay with the Quantikine ELISA Kit system. Clinical observation was carried out regularly.Three months later, the biomicroscopic photograph of posterior capsule and the pathological changes of posterior lens capsule were observed by microscopy.Results: IL-1β level in aqueous humors of ASODN group during 1-7 days after operation were significantly lower than those in the control and liposome groups.Three months after the operation, the transparency of the lens posterior capsule in the drug experimental group was superior to that in the control group (P0.05). The lens posterior capsule was covered by a layer of lens epithelium in the control group, while the lens epithelium could hardly been observed on the lens posterior capsule in the ASODN group. Conclusion: Antisense oligodeoxynucleotid liposomes of IL-1β may effectively prevent posterior capsular opacification.
What problem does this paper attempt to address?